One of the primary challenges in using biomarkers is their specificity and sensitivity. Some biomarkers may not be exclusively associated with one type of disease, leading to potential false positives or negatives. Additionally, the standardization of biomarker tests can be problematic, given variations in sample preparation, processing, and interpretation. This makes it essential to validate biomarkers in large, diverse populations.
